Engineered immune cells take on tough lymphoma in new trial
NCT ID NCT06378190
First seen Feb 06, 2026 · Last updated May 01, 2026 · Updated 9 times
Summary
This study tests a treatment called TranspoCART19 for people with B-cell lymphoma that has returned or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The main goals are to find the safest dose and see how well it works. About 27 adults will take part and be followed for 36 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL LYMPHOMA RECURRENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clínica Universidad de Navarra
RECRUITINGPamplona, Navarre, 31008, Spain
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fundación Jiménez Díaz Hospital
RECRUITINGMadrid, Madrid, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hospital Clínic
NOT_YET_RECRUITINGBarcelona, Barcelona, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut Català d'Oncologia Hospital
RECRUITINGL'Hospitalet de Llobregat, Barcelona, Spain
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Salamanca University Health Care Complex
RECRUITINGSalamanca, SALAMANCA, 37007, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Hospital of Navarra
RECRUITINGPamplona, Navarre, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Virgen de la Arrixaca University Hospital
RECRUITINGEl Palmar, Mur, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Virgen del Rocio Hospital
RECRUITINGSeville, Sevilla, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.